Upcoming earnings call puts AMN Healthcare Services (AMN) in focus

AMN Healthcare Services (AMN) is drawing attention as investors look ahead to its upcoming second quarter 2026 earnings release and conference call, along with commentary on its Managed Services Program and AI powered staffing tools.

AMN Healthcare Services’ recent share price moves show strong momentum over 2026, with a 90 day share price return of 75.18% and a year to date share price return of 119.91%, even though the 3 year and 5 year total shareholder returns remain sharply negative.

If you are assessing how healthcare workforce trends and AI tools might play out across the market, it can help to compare AMN with other companies in similar themes using our screener for 40 healthcare AI stocks

After AMN Healthcare Services’ sharp rebound and given its current price sits above the average analyst target and estimated intrinsic value, does it make more sense to step in now or wait for a pullback before committing fresh capital?

Most Popular Narrative: 12.5% Undervalued

On the most followed narrative, AMN Healthcare Services screens as undervalued, with a fair value of $38 set against the last close at $33.25. This puts a spotlight on how much weight that narrative gives to future earnings power and margins.

The consensus sees stabilization in nurse and locum bill rates supporting incremental gross margin improvement. However, accelerating orders and sharply rebounding extension rates point to a much stronger near-term surge in staffing demand, positioning AMN to capture outsized volume-driven revenue gains and materially higher net income as the healthcare labor market tightens.

Curious what has to happen for AMN Healthcare Services to justify that higher fair value? The narrative leans on shrinking revenue, margin repair, and a future earnings multiple that is far above typical healthcare benchmarks. The exact mix of growth, profitability, and required valuation is where the story gets interesting.

Result: Fair Value of $38 (UNDERVALUED)

However, there are still clear swing factors for AMN Healthcare Services, including tighter hospital labor budgets and growing use of vendor neutral or internal staffing solutions.

Another View: SWS DCF model points to limited upside

The bullish narrative around AMN Healthcare Services leans on a fair value of $38, yet our DCF model currently points to a lower figure of $30.59, with the share price at $33.25 trading above that estimate. If cash flow assumptions are closer to reality than earnings multiples, how comfortable are you with that gap?

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out AMN Healthcare Services for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 45 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

Given the mixed messages around AMN Healthcare Services, do you see a compelling opportunity or a stretched story, and how quickly are you prepared to decide? To balance the risks with what the market is optimistic about, review the 1 key reward

Looking for more investment ideas beyond AMN Healthcare Services?

If you want a fuller picture than AMN Healthcare Services alone can provide, broaden your watchlist using focused screeners that surface opportunities aligned with your style and risk tolerance.

• Jump on potential mispricings by scanning 45 high quality undervalued stocks that combine solid fundamentals with prices that may not fully reflect their underlying strength.
• Strengthen the income side of your portfolio by reviewing 9 dividend fortresses that aim to pair higher yields with resilient cash flows.
• Steady your portfolio foundation by focusing on 74 resilient stocks with low risk scores that score well on balance sheet quality and earnings consistency.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.